These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 22926606

  • 21. Propranolol as a primary treatment of neuroleptic-induced akathisia.
    Irwin M, Sullivan G, Van Putten T.
    Hillside J Clin Psychiatry; 1988; 10(2):244-50. PubMed ID: 2906317
    [Abstract] [Full Text] [Related]

  • 22. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM, Lauriello J, Laska E, Di Marino M, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [Abstract] [Full Text] [Related]

  • 23. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [Abstract] [Full Text] [Related]

  • 24. Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study.
    Kramer MS, Gorkin R, DiJohnson C.
    Hillside J Clin Psychiatry; 1989 Aug; 11(2):107-19. PubMed ID: 2577308
    [Abstract] [Full Text] [Related]

  • 25. Chronic restlessness with antipsychotics.
    Bratti IM, Kane JM, Marder SR.
    Am J Psychiatry; 2007 Nov; 164(11):1648-54. PubMed ID: 17974927
    [No Abstract] [Full Text] [Related]

  • 26. Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.
    Yoshimura B, Sato K, Sakamoto S, Tsukahara M, Yoshimura Y, So R.
    Psychopharmacology (Berl); 2019 Feb; 236(2):723-730. PubMed ID: 30443794
    [Abstract] [Full Text] [Related]

  • 27. Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales.
    Widschwendter CG, Karayal ON, Kolluri S, Vanderburg D, Kemmler G, Fleischhacker WW.
    Int J Neuropsychopharmacol; 2015 Jun 26; 18(12):. PubMed ID: 26116494
    [Abstract] [Full Text] [Related]

  • 28. Propranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled study.
    Kramer MS, Gorkin RA, DiJohnson C, Sheves P.
    Biol Psychiatry; 1988 Nov 26; 24(7):823-7. PubMed ID: 2906547
    [No Abstract] [Full Text] [Related]

  • 29. Prolonged delirium managed with risperidone.
    Bourgeois JA, Hilty DM.
    Psychosomatics; 2005 Nov 26; 46(1):90-1. PubMed ID: 15765831
    [No Abstract] [Full Text] [Related]

  • 30. The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects.
    Rasmussen SA, Rosebush PI, Mazurek MF.
    J Clin Psychopharmacol; 2017 Feb 26; 37(1):8-12. PubMed ID: 28027109
    [Abstract] [Full Text] [Related]

  • 31. A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia.
    Adler L, Angrist B, Peselow E, Corwin J, Maslansky R, Rotrosen J.
    Br J Psychiatry; 1986 Jul 26; 149():42-5. PubMed ID: 2877708
    [Abstract] [Full Text] [Related]

  • 32. No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.
    Hansen L, Jones RM, Kingdon D.
    J Psychopharmacol; 2004 Sep 26; 18(3):384-7. PubMed ID: 15358982
    [Abstract] [Full Text] [Related]

  • 33. Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
    Ranjan S, Chandra PS, Chaturvedi SK, Prabhu SC, Gupta A.
    Ann Pharmacother; 2006 Apr 26; 40(4):771-4. PubMed ID: 16569791
    [Abstract] [Full Text] [Related]

  • 34. HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia.
    Grubor M, Zivkovic M, Sagud M, Nikolac Perkovic M, Mihaljevic-Peles A, Pivac N, Muck-Seler D, Svob Strac D.
    Int J Mol Sci; 2020 Mar 28; 21(7):. PubMed ID: 32231051
    [Abstract] [Full Text] [Related]

  • 35. A case of suicidal and homicidal ideation and akathisia in a double-blind neuroleptic crossover study.
    Shaw ED, Mann JJ, Weiden PJ, Sinsheimer LM, Brunn RD.
    J Clin Psychopharmacol; 1986 Jun 28; 6(3):196-7. PubMed ID: 2872240
    [No Abstract] [Full Text] [Related]

  • 36. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Meibach RC.
    Neurology; 2000 Oct 10; 55(7):1069. PubMed ID: 11061283
    [No Abstract] [Full Text] [Related]

  • 37. Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone.
    Rosebush PI, Mazurek MF.
    Neurology; 1999 Mar 10; 52(4):782-5. PubMed ID: 10078728
    [Abstract] [Full Text] [Related]

  • 38. Akathisia with haloperidol and thiothixene.
    Van Putten T, May PR, Marder SR.
    Arch Gen Psychiatry; 1984 Nov 10; 41(11):1036-9. PubMed ID: 6497564
    [Abstract] [Full Text] [Related]

  • 39. Randomized, double-blind, crossover, placebo-controlled comparison of propranolol and betaxolol in the treatment of neuroleptic-induced akathisia.
    Dumon JP, Catteau J, Lanvin F, Dupuis BA.
    Am J Psychiatry; 1992 May 10; 149(5):647-50. PubMed ID: 1349458
    [Abstract] [Full Text] [Related]

  • 40. Response to antipsychotic medication: the doctor's and the consumer's view.
    Van Putten T, May PR, Marder SR.
    Am J Psychiatry; 1984 Jan 10; 141(1):16-9. PubMed ID: 6691455
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.